Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05069051
Title Belimumab in Patients With Chronic Lymphocytic Leukemia (BeliVeR)
Acronym BeliVeR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.